Cell Source, Inc. (CLCS) income statement
CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)
Close on Oct 19, 2026Market cap $21.99MP/E –Yield –
Cell Source, Inc. income statement
Ratios
Latest available, balances at Mar 31, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2024
- 26.4%
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?